by ADRIAN MANZ | Jul 22, 2025 | The Doctor's Dose
Netflix Earnings Beat Expectations, But Stock Dips as Growth Questions Loom Netflix (NFLX) has long been the dominant force in streaming, consistently outpacing competitors in revenue, profit, and global reach. But even the leader isn’t immune to market...
by ADRIAN MANZ | Jul 21, 2025 | The Doctor's Dose
Trump, T-Bills, and the Fed: The Hidden Battle to Curb the U.S. Interest Expense What do Donald Trump’s efforts to remove Federal Reserve Chair Jerome Powell, new legislation targeting digital stablecoins, and a shift in Treasury debt management have in common? Each...
by ADRIAN MANZ | Jul 20, 2025 | The Doctor's Dose
Interpreting the Relationship Between Session VWAP and Anchored VWAP Gain an Edge by Understanding the Volume-Weighted Context of Price Action Volume-Weighted Average Price (VWAP) is a cornerstone tool for professional traders who want to understand where the “fair...
by ADRIAN MANZ | Jul 19, 2025 | The Doctor's Dose
Why VWAP Influences Price Behavior In the fast-paced world of intraday trading, the Volume Weighted Average Price—or VWAP—acts as a magnetic line on the chart, pulling price toward it, repelling it, or serving as a pivot point for key decision-making. But what exactly...
by ADRIAN MANZ | Jul 18, 2025 | The Doctor's Dose
Copper Tariff Shocks Markets: How Investors Can Play the Surge and Brace for the Risks Copper is surging—and not just on fundamentals. President Donald Trump’s July 8 announcement of a 50% tariff on imported copper has jolted the market, sending prices to an all-time...
by ADRIAN MANZ | Jul 18, 2025 | The Doctor's Dose
Netflix Q2 2025 Earnings Beat Forecasts: Revenue Surges 16% as Streamer Raises Guidance Netflix (NASDAQ: NFLX) delivered a robust second-quarter earnings report on Thursday, exceeding Wall Street expectations and signaling continued momentum in both subscriber and ad...
by ADRIAN MANZ | Jul 17, 2025 | The Doctor's Dose
How to Prompt AI for Better Financial Advice: What Investors Need to Know Artificial intelligence is reshaping the way we research stocks, analyze sectors, and make investment decisions. However, when it comes to prompting AI for financial advice, many retail...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
AI Boom or Bubble? What the Dot-Com Era Teaches Us About Today’s Market History doesn’t repeat—but as Mark Twain famously noted, it often rhymes. With the AI stock bubble vs dot-com bubble debate heating up, investors are drawing parallels between today’s...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
Trump’s Threat to Fire Powell Rattles Markets and Sparks Fears Over Fed Independence By Adrian Manz Markets sent a strong signal Wednesday: tampering with Federal Reserve independence comes with consequences. When President Donald Trump floated the idea of firing Fed...
by ADRIAN MANZ | Jul 16, 2025 | The Doctor's Dose
Tariff-Driven Rally May Be Topping Out—Time to Take Profits or Go Short? Markets have surged in recent months on the back of easing tariff tensions—but that rally may be running out of steam. For active traders and tactical investors, this could be a prime opportunity...
